KEGG   DRUG: Glecaprevir - pibrentasvir mixtHelp
Entry
D11014            Mixture   Drug                                   

Name
Glecaprevir - pibrentasvir mixt;
Mavyret (TN)
Product
Component
(Glecaprevir [DR:D10814] | Glecaprevir hydrate [DR:D10815]), Pibrentasvir [DR:D10816]
Remark
Therapeutic category: 6250
Product: D11014<JP/US>
Efficacy
Antiviral
  Disease
Chronic hepatitis C virus infection [DS:H00413]
Interaction
Drug interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D11014  Glecaprevir - pibrentasvir mixt
Antiinfectives [br08350.html]
 Antivirals
  D11014
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D11014
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11014
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11014
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11014
BRITE hierarchy
Other DBs
PubChem: 348350486
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system